Expression of Cathepsin-D in Primary Breast Cancer and Corresponding Local Recurrence or Metastasis: An Immunohistochemical Study

被引:0
作者
Dian, D. [1 ]
Vrekoussis, T. [1 ]
Shabani, N. [1 ]
Mylonas, I. [1 ]
Kuhn, C. [1 ]
Schindlbeck, C. [1 ]
Navrozoglou, I.
Friese, K. [1 ,2 ]
Makrigiannakis, A. [3 ]
Jeschke, U. [1 ]
机构
[1] Univ Munich, Dept Obstet & Gynecol 1, Munich, Germany
[2] Univ Ioannina, Sch Med, Dept Obstet & Gynecol, GR-45110 Ioannina, Greece
[3] Univ Crete, Sch Med, Dept Obstet & Gynecol, Iraklion, Greece
关键词
Cathepsin-D; breast cancer; local recurrence; metastasis; immunohistochemistry; PROCATHEPSIN-D; D GENE; CELLS; TUMOR; APOPTOSIS; PROTEIN; GROWTH; PROLIFERATION; INVASION; MARKER;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background/Aim: The role of cathepsin-D is well established in breast cancer progression, being correlated with worse clinical outcomes. However, to our knowledge, no study has been performed investigating its expression in primary breast cancer tumors and their corresponding recurrences or metastasis. Materials and Methods: Tissue sections from ten breast cancer cases and their corresponding local recurrences and six breast cancer cases and their corresponding metastases were bnmunohistochemically assessed for cathepsin-D reactivity. Cases diagnosed as either ductal carcinoma in situ (n=7), or breast carcinoma with no evidence of local recurrence or metastasis during follow-up (n=8) served as controls. Results: Cathepsin-D was significantly up-regulated in all the study groups compared to controls. No difference was found between primary tumors and their corresponding recurrences or metastases. Conclusion: Cathepsin-D-expressing breast cancer cells seem to be involved in local recurrence or metastasis formation. Large series are needed to further verify this result with the aim of possible future molecular intervention.
引用
收藏
页码:901 / 905
页数:5
相关论文
共 23 条
[11]   Post-translational modifications of the extracellular matrix are key events in cancer progression: Opportunities for biochemical marker development [J].
Leeming, D. J. ;
Bay-Jensen, A. C. ;
Vassiliadis, E. ;
Larsen, M. R. ;
Henriksen, K. ;
Karsdal, M. A. .
BIOMARKERS, 2011, 16 (03) :193-205
[12]   Cathepsin D:: newly discovered functions of a long-standing aspartic protease in cancer and apoptosis [J].
Liaudet-Coopman, Emmanuelle ;
Beaujouin, Melanie ;
Derocq, Danielle ;
Garcia, Marcel ;
Glondu-Lassis, Murielle ;
Laurent-Matha, Valerie ;
Prebois, Christine ;
Rochefort, Henri ;
Vignon, Francoise .
CANCER LETTERS, 2006, 237 (02) :167-179
[13]   Pathophysiological functions of cathepsin D: Targeting its catalytic activity versus its protein binding activity? [J].
Masson, Olivier ;
Bach, Anne-Sophie ;
Derocq, Danielle ;
Prebois, Christine ;
Laurent-Matha, Valerie ;
Pattingre, Sophie ;
Liaudet-Coopman, Emmanuelle .
BIOCHIMIE, 2010, 92 (11) :1635-1643
[14]   The dilemma: Does tissue expression of cathepsin D reflect tumor malignancy? The question: Does the assay truly mirror cathepsin D mis-function in the tumor? [J].
Nicotra, Giuseppina ;
Castino, Roberta ;
Follo, Carlo ;
Peracchio, Claudia ;
Valente, Guido ;
Isidoro, Ciro .
CANCER BIOMARKERS, 2010, 7 (01) :47-64
[15]  
Ohri SS, 2008, INT J ONCOL, V32, P491
[16]   Depletion of procathepsin D gene expression by RNA interference - A potential therapeutic target for breast cancer [J].
Ohri, Sujata Saraswat ;
Vashishta, Aruna ;
Proctor, Mary ;
Fusek, Martin ;
Vetvicka, Vaclav .
CANCER BIOLOGY & THERAPY, 2007, 6 (07) :1081-1087
[17]  
REMMELE W, 1987, PATHOLOGE, V8, P138
[18]   Cathepsin D in cancer metastasis: A protease and a ligand [J].
Rochefort, H ;
Liaudet-Coopman, E .
APMIS, 1999, 107 (01) :86-95
[19]   Causes and consequences of tumour acidity and implications for treatment [J].
Stubbs, M ;
McSheehy, PMJ ;
Griffiths, JR ;
Bashford, CL .
MOLECULAR MEDICINE TODAY, 2000, 6 (01) :15-19
[20]  
Têtu B, 1999, BREAST CANCER RES TR, V55, P137